← Home
The Ezra Klein Show · May 8, 2026 · 1h 13m

GLP-1s and the 'Wild West' of Wellness

Julia Belluz
Apple PodcastsShow Notes

Julia Belluz, a health and science journalist, explores the explosion of GLP-1 drugs like Ozempic and Zepbound, which one in eight American adults now use. The episode examines what we know and don't know about these medications, their unexpected uses beyond diabetes, how they're reshaping conversations about beauty standards and wellness, and whether these drugs represent genuine medical progress or a new frontier for pharmaceutical-driven culture.

This summary was generated from show notes and public descriptions, not from a full transcript review. Details may contain inaccuracies.

Highlights

•
One in Eight Americans Now Uses GLP-1 Drugs
A KFF poll shows that one out of every eight American adults is taking a GLP-1 drug like Ozempic or Zepbound, representing unprecedented pharmaceutical adoption.
ClaudeChatGPTGemini
•
GLP-1s as the Biggest Pharma Story Since Antidepressants
GLP-1s represent a watershed moment in pharmaceutical history comparable to the introduction of antidepressants, yet much uncertainty remains about long-term effects and appropriate use.
ClaudeChatGPTGemini
•
We're Still at the Beginning of Understanding GLP-1 Benefits and Harms
Despite mass adoption, we remain early in understanding the full range of benefits and harms of GLP-1 drugs, with long-term effects still unknown.
ClaudeChatGPTGemini

Editorial

•
GLP-1s Blur the Line Between Medicine and Cosmetic Intervention
GLP-1s are entering a 'Wild West' phase where they're being prescribed and used for aesthetic goals (looksmaxxing, thinness) rather than medical conditions, forcing a reckoning with how we define illness and wellness.
ClaudeChatGPTGemini
•
Beauty Standards Are Being Pharmaceutically Enforced
The widespread use of GLP-1s for aesthetic reasons reflects and reinforces cultural obsession with thinness, creating a new form of beauty-standard enforcement through medicine rather than willpower alone.
ClaudeChatGPTGemini

References

■
Behave — Robert M. Sapolsky — Recommended by Belluz
■
The Poison Squad — Deborah Blum — Recommended by Belluz
■
Ultra-Processed People — Chris van Tulleken — Recommended by Belluz
■
Food Intelligence — Julia Belluz and Kevin Hall — Belluz's co-authored book

Misc

✧One in eight American adults is now on a GLP-1 drug—a staggering adoption rate for any pharmaceutical.
✧GLP-1s are called the biggest pharma story since antidepressants, yet uncertainty remains about long-term effects.
✧The drugs are reshaping cultural conversation about thinness, beauty standards, and the definition of wellness.
✧Belluz describes GLP-1s as entering a 'Wild West' phase where off-label uses and aesthetic goals blur lines between medicine and cosmetic intervention.
Was this useful?